Evidence map›Paper›PMID 41853331›Full record

ArticleKidney medicine2026

Oxalate Nephropathy in a Patient With Chronic Pancreatitis and Recent Surgery: A Clinical Conundrum.

Robert Seby, Krista Grennan, Jacob Henderson, Cene Ovincy, Fadi Salem, John Lieske, Ivan Porter, LaTonya Hickson

Abstract readCase Reports
In one paragraph

Article in Kidney medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Robert SebyDepartment of Internal Medicine, Mayo Clinic, Jacksonville, FL.
Krista GrennanDepartment of Internal Medicine, Mayo Clinic, Jacksonville, FL.
Jacob HendersonDivision of Nephrology and Hypertension, Department of Internal Medicine, Mayo Clinic, Jacksonville, FL.
Cene OvincyDivision of Nephrology and Hypertension, Department of Internal Medicine, Mayo Clinic, Jacksonville, FL.
Fadi SalemDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Jacksonville, FL.
John LieskeDivision of Nephrology and Hypertension, Department of Internal Medicine, Mayo Clinic, Rochester, MN.
Ivan PorterDivision of Nephrology and Hypertension, Department of Internal Medicine, Mayo Clinic, Jacksonville, FL.
LaTonya HicksonDivision of Nephrology and Hypertension, Department of Internal Medicine, Mayo Clinic, Jacksonville, FL.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Calcium oxalate nephropathy is a rare condition with both primary and secondary causes. Primary hyperoxaluria, an inherited disorder, leads to liver oxalate overproduction, whereas secondary hyperoxaluria, or enteric hyperoxaluria, may be multifactorial and typically occurs during adulthood, with etiologies including increased dietary intake of oxalate, destruction of the microbiota in the gastrointestinal tract that break down oxalate, and malabsorptive disorders that increase serum oxalate levels. Calcium oxalate crystal deposition can cause irreversible kidney injury necessitating kidney replacement therapy. Prompt recognition of the underlying etiology is necessary to minimize complications. Here, we present a case of calcium oxalate nephropathy of unclear initial etiology. Further consideration is given to alternative therapeutic options that address oxalate deposition-associated interstitial inflammation.

Indexed as

Chronic kidney diseasedialysishyperoxaluriainterstitial nephritisoxalate nephropathy

Identifiers

PMID41853331
PMCPMC12992932

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.